Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01950065 · ClinicalTrials.gov registry record · NA
Effectiveness and Safety Study of the Iovera Device for the Temporary Reduction in the Appearance of Forehead Wrinkles
A NA study, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT01950065 is a NA study that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 85 participants.
The verdict
NCT01950065, a NA study, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
Evaluate the effectiveness and safety of the iovera device for the temporary reduction in the appearance of forehead wrinkles.
Interventions
- DEVICE iovera
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2013-09 |
| Est. Completion | 2014-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01950065
The ClinicalTrials.gov registry entry for NCT01950065 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which iovera is the first listed.
NCT01950065 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01950065 about?
NCT01950065 is a clinical study titled "Effectiveness and Safety Study of the Iovera Device for the Temporary Reduction in the Appearance of Forehead Wrinkles". Evaluate the effectiveness and safety of the iovera device for the temporary reduction in the appearance of forehead wrinkles.
What is the current status of trial NCT01950065?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2013-09. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01950065?
The interventions under investigation include: iovera (DEVICE).
Who is sponsoring clinical trial NCT01950065?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.